These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37377795)

  • 1. Investigation of Methyl-5-(pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxyhydrazide Derivatives as Potential Inhibitors of COVID-19 Main Protease: DFT and Molecular Docking Study.
    Akinyele OF; Fakola EG; Adeboye OO; Chinuomah SC
    Bioinform Biol Insights; 2023; 17():11779322231182050. PubMed ID: 37377795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations.
    Amin MR; Yasmin F; Dey S; Mahmud S; Saleh MA; Emran TB; Hasan I; Rajia S; Ogawa Y; Fujii Y; Yamada M; Ozeki Y; Kawsar SMA
    Glycoconj J; 2022 Apr; 39(2):261-290. PubMed ID: 35037163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico Molecular Docking, DFT Analysis and ADMET Studies of Carbazole Alkaloid and Coumarins from Roots of
    Eswaramoorthy R; Hailekiros H; Kedir F; Endale M
    Adv Appl Bioinform Chem; 2021; 14():13-24. PubMed ID: 33584098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz.
    Jordaan MA; Ebenezer O; Damoyi N; Shapi M
    Heliyon; 2020 Aug; 6(8):e04642. PubMed ID: 32802982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking, drug-likeness and DFT study of some modified tetrahydrocurcumins as potential anticancer agents.
    Mahal A; Al-Janabi M; Eyüpoğlu V; Alkhouri A; Chtita S; Kadhim MM; Obaidullah AJ; Alotaibi JM; Wei X; Pratama MRF
    Saudi Pharm J; 2024 Jan; 32(1):101889. PubMed ID: 38090737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis.
    Liu J; Zhang L; Gao J; Zhang B; Liu X; Yang N; Liu X; Liu X; Cheng Y
    Front Pharmacol; 2022; 13():961154. PubMed ID: 36091808
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies.
    Murali M; Gowtham HG; Shilpa N; Krishnappa HKN; Ledesma AE; Jain AS; Shati AA; Alfaifi MY; Elbehairi SEI; Achar RR; Silina E; Stupin V; Ortega-Castro J; Frau J; Flores-Holguín N; Amruthesh KN; Shivamallu C; Kollur SP; Glossman-Mitnik D
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidation of escitalopram oxalate and related antidepressants as putative inhibitors of PTP4A3/PRL-3 protein in hepatocellular carcinoma: A multi-computational investigation.
    Mir IH; Shyam KT; Balakrishnan SS; Kumar MS; Ramesh T; Thirunavukkarasu C
    Comput Biol Chem; 2024 Jun; 110():108039. PubMed ID: 38471352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
    Cetin A
    Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying the Biological Activity of Trans-[Cu (quin)2(EtOH)2] as Potent Antimicrobial Cu(II) Complex through Computational Investigations: DFT, ADMET and Molecular Docking.
    Hussein RK; El-Khayatt AM; Duaij OKA; Alkaoud AM
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):84. PubMed ID: 37114549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic.
    Muteeb G; Alshoaibi A; Aatif M; Rehman MT; Qayyum MZ
    Appl Biol Chem; 2020; 63(1):79. PubMed ID: 33251389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Some Antiviral
    Hagar M; Ahmed HA; Aljohani G; Alhaddad OA
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of phenolic acid derivatives as inhibitors of SARS-CoV-2 main protease and receptor binding domain: potential candidates for anti-SARS-CoV-2 therapy.
    Shafiq N; Mehroze A; Sarwar W; Arshad U; Parveen S; Rashid M; Farooq A; Rafiq N; Wondmie GF; Bin Jardan YA; Brogi S; Bourhia M
    Front Chem; 2023; 11():1251529. PubMed ID: 37822772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19.
    Rai H; Barik A; Singh YP; Suresh A; Singh L; Singh G; Nayak UY; Dubey VK; Modi G
    Mol Divers; 2021 Aug; 25(3):1905-1927. PubMed ID: 33582935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular structure, NBO analysis of the hydrogen-bonded interactions, spectroscopic (FT-IR, FT-Raman), drug likeness and molecular docking of the novel anti COVID-2 molecule (2E)-N-methyl-2-[(4-oxo-4H-chromen-3-yl)methylidene]-hydrazinecarbothioamide (Dimer) - quantum chemical approach.
    Jenepha Mary SJ; Pradhan S; James C
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Apr; 251():119388. PubMed ID: 33503560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp.
    Murali M; Gowtham HG; Ansari MA; Alomary MN; Alghamdi S; Almehmadi M; Singh SB; Shilpa N; Aiyaz M; Kalegowda N; Ledesma AE; Amruthesh KN
    Curr Pharm Des; 2022; 28(12):969-980. PubMed ID: 35796443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand based-design of potential schistosomiasis inhibitors through QSAR, homology modeling, molecular dynamics, pharmacokinetics, and DFT studies.
    Ja'afaru SC; Uzairu A; Chandra A; Sallau MS; Ndukwe GI; Ibrahim MT; Qamar I
    J Taibah Univ Med Sci; 2024 Apr; 19(2):429-446. PubMed ID: 38440085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.